Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 026 602.9 |
96 | EP file number | EAKZ | 14 70 4040.6 |
86 | WO file number | WAKZ | PCT/US2014/013402 |
97 | EP publication number | EPN | 2948476 |
87 | WO publication number | WPN | 2014117160 |
54 | Designation/title | TI | ANTI-FLT-1-ANTIKÖRPER ZUR BEHANDLUNG DER DUCHENNE-MUSKELDYSTROPHIE |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01) |
22 | DE application date | DAT | Jan 28, 2014 |
96 | EP application date | EAT | Jan 28, 2014 |
86 | WO application date | WAT | Jan 28, 2014 |
43 | Date of first publication | OT | Jul 31, 2014 |
| Date of publication of grant | PET | Jun 6, 2018 |
71/73 | Applicant/owner | INH | Regents of the University of Minnesota, Minneapolis, Minn., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | JOSIAH, Serene, Lexington, Massachusetts 02421, US; LUBY, Thomas M., Lexington, Massachusetts 02421, US; ASAKURA, Atsushi, Minneapolis, Minnesota 55455, US; KEEFE, Dennis, Lexington, Massachusetts 02421, US; CHARNAS, Lawrence, Natick, Massachusetts 01760, US; VERMA, Mayank, Minneapolis, MN 55455, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361757571 P Jan 28, 2013
|
| Due date | FT FG | Jan 31, 2026 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002948476 Searchable text:
EP000002948476 Original document:
EP000002948476B1 Searchable text:
EP000002948476B1 Original document:
WO002014117160 Searchable text:
WO002014117160 |
43 | Date of first publication | EVT | Jul 31, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Dec 3, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 11, 2025 (Show all update days)(Hide all update days)- Jan 11, 2025
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 31.07.2014: deleted
- Jan 6, 2024; Jan 14, 2023; Dec 22, 2021; Oct 14, 2021; Sep 7, 2021; Jan 13, 2021; Jan 11, 2020; Aug 16, 2019; May 29, 2019; Apr 25, 2019; Feb 14, 2019; Jan 9, 2019; Jun 28, 2018; May 29, 2018; May 24, 2018; Jan 4, 2018
- Historical data not available for this/these date(s)
- Dec 3, 2015
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 6, 2021 |
| Issue number | HN | 41 |
| Year | PJ | 2021 |
| Publication date | VT | Oct 14, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Regents of the University of Minnesota, Minneapolis, Minn., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
71/73 | Previous applicant/owner | INHF | Regents of the University of Minnesota, Minneapolis, Minn., US, Shire Human Genetic Therapies, Inc., Lexington, Mass., US |
| Date of update of the procedure | REGT | Oct 14, 2021 |